Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.

about

Fetal presentation of congenital dyserythropoietic anemia type 1 with novel compound heterozygous CDAN1 mutations.

Item

http://www.wikidata.org/entity/Q52723154

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@en

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@nl

type

Item

label

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@en

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@nl

prefLabel

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@en

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@nl

P1476

Fetal presentation of congenit ...... heterozygous CDAN1 mutations.

@en

P2093

Diane M Ward

http://www.w3.org/2001/XMLSchema#string

Elizabeta Nemeth

http://www.w3.org/2001/XMLSchema#string

Grace Jung

http://www.w3.org/2001/XMLSchema#string

Hassan M Yaish

http://www.w3.org/2001/XMLSchema#string

Jessica A Meznarich

http://www.w3.org/2001/XMLSchema#string

Lauren Draper

http://www.w3.org/2001/XMLSchema#string

Nick D Luem

http://www.w3.org/2001/XMLSchema#string

Robert D Christensen

http://www.w3.org/2001/XMLSchema#string

Theodore J Pysher

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of erythroferrone as an erythroid regulator of iron metabolism

The erythrocyte indices of neonates, defined using data from over 12,000 patients in a multihospital health care system.

A comprehensive study of the neonatal manifestations of congenital dyserythropoietic anemia type I.

Reference ranges for hematocrit and blood hemoglobin concentration during the neonatal period: data from a multihospital health care system.

Congenital dyserythropoietic anemia type I presenting as persistent pulmonary hypertension of the newborn.

Elevated growth differentiation factor 15 expression in patients with congenital dyserythropoietic anemia type I.

Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia.

Ferroportin-mediated iron transport: expression and regulation.

Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I

Congenital dyserythropoietic anemias: molecular insights and diagnostic approach

P31

scholarly article

P356

10.1016/J.BCMD.2018.03.002

http://www.w3.org/2001/XMLSchema#string

P50

Tomas Ganz

P577

2018-03-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29599085

http://www.w3.org/2001/XMLSchema#string

P932

5947870

http://www.w3.org/2001/XMLSchema#string